Resolves to Yes if any company in the S&P 500 Pharmaceuticals or Biotech index announces a spinoff of its off-patent or generics business.
Resolves Yes if Resolves to Yes if any company in the S&P 500 Pharmaceuticals or Biotech index announces a spinoff of its off-patent or generics business.
Outcome verified from reuters.com.
Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.
Analyzing this market…